New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
08:09 EDTMELAMELA Sciences initiates study on clinical impact of MelaFind on melanoma biopsy
MELA Sciences announced that it has initiated a study to examine the real-world clinical impact of MelaFind on dermatologists' decision to biopsy pigmented skin lesions that are suspicious for melanoma. CEO Rose Crane commented, "This trial is significant as the data will be based on patient assessments by dermatologists using the MelaFind system. It will provide us with a measure of the real-world clinical impact of MelaFind on melanoma diagnosis, and we believe it will support our case for insurance reimbursement. We welcome Dr. Rigel's oversight as the principal investigator of this important study."
News For MELA From The Last 14 Days
Check below for free stories on MELA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2014
08:05 EDTMELAMELA Sciences and Columbia University to collaborate in MelaFind system research
Subscribe for More Information
August 20, 2014
10:44 EDTMELAMELA Sciences files to sell 21.64M shares of common stock for holders
Subscribe for More Information
August 18, 2014
10:01 EDTMELAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:11 EDTMELAMELA Sciences initiated with a Buy at H.C. Wainwright
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use